20th Annual Cardiometabolic Health Congress: Applying Clinical Pearls to Practice
October 23-25, 2025 at the Hilton Boston Park Plaza, Boston, MA
This activity is supported in part by an independent educational grant from Novartis Pharmaceuticals Corporation and Amgen.
The educational design of this activity addresses the needs of US-based healthcare professionals, including cardiologists, endocrinologists, lipidologists, primary care clinicians (PCPs), registered nurses, advanced practice registered nurses, dieticians, pharmacists, and other allied health professionals involved in the management and treatment of cardiometabolic patients.
After completing this activity, the participant should be better able to:
1. Describe the connections between cardiometabolic risk factors and their collective influence on the progression of cardiometabolic diseases, including diabetes, dyslipidemia, hypertension, obesity, kidney disease, and cardiovascular disease
2. Analyze recent evidence and guidelines to enhance the prevention, screening, and management of patients with cardiometabolic risk or established cardiometabolic disease
3. Identify effective strategies for early detection and prevention of cardiometabolic disease, including comprehensive risk factor assessment and lifestyle interventions
4. Design personalized treatment plans for patients with cardiometabolic disease by integrating current and emerging pharmacotherapies, considering safety, efficacy, comorbidities, and patient preferences to improve outcomes
5. Summarize the latest advancements in cardiometabolic therapies to remain informed on the evolving landscape of treatment options
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and Cardiometabolic Health Congress (CMHC). Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
*Credit hours subject to change
Partners designates this live activity for a maximum of 18* AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The maximum number of hours awarded for this Continuing Nursing Education activity is 18 *contact hours.
Pharmacotherapy contact hours for Advance Practice Registered Nurses will be designated on your certificate.
Partners designates this continuing education activity for 18* contact hour(s) (1.8* CEUS) of the Accreditation Council for Pharmacy Education.
This program offers 18* CPEUs for dietitians.
There is a registration fee for participating and receiving CME/CE credit for this educational activity. Registration information can be found here.
Learners may earn up to 18 AMA/ACPE/ANCC/CDR credits for attending all general sessions and satellite symposia.
Following the Annual meeting, all registered attendees will receive an email with an evaluation link. To streamline the process, you can create an account in advance with our CME provider, Partners for Advancing Clinical Education, where the evaluation will be hosted. Please SIGN UP here: https://cme.partnersed.com.
For Pharmacists: Pharmacists have up to thirty (30) days to complete the evaluation and claim credit. Credit will be submitted automatically to CPE Monitor. Please check your NABP account within thirty (30) days to make sure the credit has posted.
Several email reminders will be sent post-meeting and credit can only be obtained by accessing the links provided. Please claim your CE credits by completing the evaluation by November 30, 2025.
Partners requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships.
Information on faculty disclosures will be availble before the meeting.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.